MSD’s colorectal cancer treatment approved by NICE
May 14, 2021Medical Communications
Pembrolizumab (Keytruda), for people with untreated metastatic colorectal cancer who have specific mutations in their cancer cells, has been approved …
Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows
May 14, 2021Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news
The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …
Biogen to collaborate with Envisagenics on RNA splicing research
May 14, 2021Medical Communications AI
Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …
Major ovarian cancer screening trial fails to reduce deaths
May 14, 2021Medical Communications
A major trial involving 200,000 women to detect ovarian cancer has failed to save lives after two decades of work. …
India approves Covaxin clinical trials for children aged 2-18 years old
May 13, 2021The Drugs Controller General of India (DCGI) has cleared Bharat Biotech’s Covaxin trials on children from 2-18 years old. The …
AstraZeneca and Amgen asthma drug shows positive results in Phase III trial
May 13, 2021Amgen, AstraZeneca, asthma, asthma treatment, pharma, pharma news, severe asthma
AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority across all primary and secondary …
Sanofi’s Libtayo shows positive Phase III results in advanced cervical cancer
May 13, 2021Libtayo, Sanofi, cemiplimab, cervical cancer
Regeneron Pharmaceuticals and Sanofi have announced today positive Phase III trial results investigating the PD-1 inhibitor Libtayo (cemiplimab) in patients …
Rinri Therapeutics secures £3.2 million grant for hearing loss therapy
May 13, 2021Stem cells
Sheffield-based biotech company, Rinri Therapeutics, have secured a £3.2 million grant from Innovate UK to further develop Rinri’s novel stem …
Exscientia launch trial of third AI-designed molecule
May 13, 2021AI, Altzeimer's, Exscientia
Exscientia has launched Phase I trials in the US of DSP-0038 for the treatment of Alzheimer’s disease psychosis, the third …
Pharmafile.com’s weekly COVID-19 news round-up
May 12, 2021Research and Development COVID-19
The past week has seen India’s highest number of COVID-19 deaths, with 4,205 fatalities in a single day. There has …
India report record number of COVID deaths as bodies drift down Ganges
May 12, 2021Research and Development COVID-19, India, Indian COVID crisis, covid 19 news, covid-19 news, pharma, pharma news
India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.
Astellas prostate cancer drug gets third approval from MHRA
May 12, 2021Research and Development Astellas, MHRA, cancer research, cancer treatment, pharma, pharma news, prostate cancer
The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making …
NICE rejects Pfizer’s Vyndaqel for treating rare heart condition
May 12, 2021Research and Development NICE, Pfizer, Vyandaqel
NICE has published final guidance today which rejects tafamidis, also known as Vyndaqel, for treating rare heart condition transthyretin amyloidosis …
Endogena’s retinitis pigmentosa treatment granted Orphan Drug Designation by FDA
May 12, 2021Research and Development DFA, Endogena, Orphan Drug Designation
Endogena Therapeutics Inc has been granted Orphan Drug Designation for its EA-2353 ophthalmic suspension targeting retinitis pigmentosa by the FDA. …
Eli Lilly and MiNA Therapeutics to collaborate on saRNA research
May 12, 2021Research and Development Eli Lilly
Eli Lilly and MiNA Therapeutics have announced a global research collaboration to develop novel drug candidates using MiNA’s proprietary small …
Bayer’s cardiovascular drug shows impressive Phase III results
May 11, 2021Manufacturing and Production Bayer, chronic kidney disease, pharma, pharma news, type 2 diabetes
Bayer’s finerenone drug has been shown to significantly reduce cardiovascular death or other cardiovascular events in patients with chronic kidney …
Abbvie psoriatic arthritis drug approved for use in Scotland
May 11, 2021Manufacturing and Production AbbVie, NHS, arthritis, psoriatic arthritis
Abbvie’s RINVOQ (upadacitinib) drug, for the treatment of active psoriatic arthritis (PsA) in adults, has been approved for use in …
FDA authorizes use of Pfizer vaccine for children aged 12-15
May 11, 2021Manufacturing and Production COVID-19, FDA, Pfizer, Vaccine
The FDA announced it has expanded the emergency use of the Pfizer-BioNTech vaccine in children aged 12-15 yesterday.It was determined …
Facio Therapies announces AI collaboration for FSHD drug design
May 11, 2021Manufacturing and Production AI, drug discovery
Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …
Biogen and Capsigen to collaborate on novel gene therapies
May 11, 2021Manufacturing and Production gene therapy
Biogen and Capsigen have announced a research collaboration to engineer novel adeno-associated virus (AAV) capsids that have the potential to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
